APA (7th ed.) Citation

Harris, A. G., Saikal, S. L., Scurry, J., Relic, J., Nixon, R. L., & Chee, P. (2019). Severe cutaneous eruptions following the topical use of preparations containing bufexamac: Is it time to reconsider its registration in Australia? Australasian Journal of Dermatology, 60(1), 53. https://doi.org/10.1111/ajd.12910

Chicago Style (17th ed.) Citation

Harris, Adam G., Samra L. Saikal, Jim Scurry, John Relic, Rosemary L. Nixon, and Paul Chee. "Severe Cutaneous Eruptions Following the Topical Use of Preparations Containing Bufexamac: Is It Time to Reconsider Its Registration in Australia?" Australasian Journal of Dermatology 60, no. 1 (2019): 53. https://doi.org/10.1111/ajd.12910.

MLA (9th ed.) Citation

Harris, Adam G., et al. "Severe Cutaneous Eruptions Following the Topical Use of Preparations Containing Bufexamac: Is It Time to Reconsider Its Registration in Australia?" Australasian Journal of Dermatology, vol. 60, no. 1, 2019, p. 53, https://doi.org/10.1111/ajd.12910.